HUM vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Feb 02, 2026

HUM

55.2
AI Score
VS
HUM Wins

CLOV

52.2
AI Score

Investment Advisor Scores

HUM

55score
Recommendation
HOLD

CLOV

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HUM CLOV Winner
Forward P/E 18.5185 94.3396 HUM
PEG Ratio 0.9962 0 Tie
Revenue Growth 11.1% 50.1% CLOV
Earnings Growth -59.3% 0.0% CLOV
Tradestie Score 55.2/100 52.2/100 HUM
Profit Margin 1.0% -3.3% HUM
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, HUM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.